At this time, posts about AhnLab are rapidly increasing on portals and securities communities, while foreign investors are tentatively estimated to have net sold 22,000 shares today. AhnLab is known as a company specializing in vaccine software development.
As of 1:30 PM on the 11th, AhnLab's stock price is 96,700 KRW, down 6.03% from the previous day, with a trading volume of 529,556 shares, which is 48.46% of the 5-day average trading volume. On January 7th, AhnLab was a market issue with the headline "Strong early session... Will the 9-day consecutive rise continue?"
In addition to AhnLab, posts by investors are also rapidly increasing for OCI (010060), Selma Therapeutics (015540), and SY (109610).

※Source: AI Investment Assistant AI Lassi
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
